Financing channel feed – Endpoints News

Financing channel feed

Karyopharm cuts 20% of staff as it looks at 'strategic alternatives' or raising cash

Yesterday

Biotech’s Q2 numbers paint a picture of the good, the bad and the ugly

2 days ago

Kidney health biotech emerges with $54M to follow in Vertex’s footsteps

2 days ago

Swiss and German radiopharma biotech Nuclidium collects $99M Series B

2 days ago

Aqtual raises $31M to guide rheumatoid arthritis treatments

2 days ago

CoRegen closes $93M financing round to enter the clinic and expand its leadership team

3 days ago

Nimble radiopharma biotech Actithera gets $75M to enter the clinic

3 days ago

Health tech startups raise $6.4B in first half of 2025 in AI frenzy

5 days ago

Number of megarounds drops 38% in first half as biotechs struggle against worsening slump

Last week

Exclusive: VC firm lines up $200M fund to champion Japanese innovation

Last week

Exclusive: Sama Fertility raises $3.8M to make IVF more accessible

Last week

Exclusive: Bob Langer-founded Syntis Bio gets $33M Series A for obesity, rare disease drugs

Last week

Apple Tree Partners' biotechs 'face imminent collapse' as firm battles Russian investor in court

Last week

Exclusive: Handspring Health raises $12M to provide more complex youth mental healthcare

3 weeks ago

Vor Bio bounces back with autoimmune drug pact, $175M private placement

3 weeks ago

Revolution inks up to $2B 'flexible' funding deal to advance RAS inhibitor pipeline

3 weeks ago

Early-stage investor Syncona readjusts priorities due to bleak biotech market

4 weeks ago

Tennr raises $101M Series C to fix faxes with AI

4 weeks ago

Actio gets $66M for experimental epilepsy and Charcot-Marie-Tooth treatments

4 weeks ago

Sanofi-backed Welsh biotech secures $140M for neuropsychiatry pipeline

4 weeks ago

Insmed aims to raise $750M in one of the largest stock offerings this year

5 weeks ago

Exclusive: Commons Clinic raises $26M Series B to offer preventive testing

5 weeks ago

Gene therapy biotech SpliceBio gets $135M shortly after starting first clinical trial

Last month

Exclusive: Scorpion spinout gets $177M for stealthy pipeline amid China competition

Last month

12 3 4 Next page Last page